Literature DB >> 8605487

Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Mortality due to C difficile colitis in elderly people has been underestimated.

M Lesna, D M Parham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8605487      PMCID： PMC2350454          DOI： 10.1136/bmj.312.7033.778a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

Authors:  M Impallomeni; N P Galletly; S J Wort; J M Starr; T R Rogers
Journal:  BMJ       Date:  1995-11-18
  1 in total
  4 in total

Review 1.  Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

Authors:  R N Brogden; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 2.  Mechanisms of drug-induced diarrhoea in the elderly.

Authors:  R N Ratnaike; T E Jones
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 4.271

Review 3.  Mortality in hospitalized older adults associated with Clostridium difficile infection at a district hospital.

Authors:  Johannis Andreas Karas; Simon Bradshaw; Wabbas Mahmud; David A Enoch
Journal:  Infect Dis Rep       Date:  2010-06-21

Review 4.  Severe acute diarrhea.

Authors:  Julia I Gore; Christina Surawicz
Journal:  Gastroenterol Clin North Am       Date:  2003-12       Impact factor: 3.806
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.